Osborne Clarke has advised Grifols on the deal. Grifols signed an agreement with the Hong Kong’s Tiancheng International Investment Ltd. to acquire 100% of the shares...
Grifols’ EUR1.1 Billion Acquisition Of Biotest
Grifols’ USD 1 Billion Strategic Investment From GIC
Osborne Clarke and Proskauer advised Grifols on the deal, while Dechert advised GIC. As part of the transaction, GIC will become a strategic investor in Grifols’...
Grifols’ $55.2 Million Acquisition of Seven Plasma Centres
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
Grifols’ $55.2 Million Acquisition of Seven Plasma Centres
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
Grifols’ $80 Million Acquisition of Remaining Stake in GigaGen
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of remaining 56 per cent share capital in GigaGen Inc., for USD 80 million. GigaGen is a...
Grifols’ $370 Million Acquisition of 25 US-based Plasma Centres
Osborne Clarke advised Grifols on the deal while Greenberg Traurig, LLP represented Tiancheng Investment Management and its portfolio company Bio Products Laboratory. Grifols executed the $370...